These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8733937)

  • 1. Oxidation of low-density lipoprotein by human monocyte-macrophages results in toxicity to the oxidising culture.
    Marchant CE; Van der Veen C; Law NS; Hardwick SJ; Carpenter KL; Mitchinson MJ
    Free Radic Res; 1996 May; 24(5):333-42. PubMed ID: 8733937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant BO-653 and human macrophage-mediated LDL oxidation.
    Müller K; Carpenter KL; Freeman MA; Mitchinson MJ
    Free Radic Res; 1999 Jan; 30(1):59-71. PubMed ID: 10193574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low-density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants.
    Marchant CE; Law NS; van der Veen C; Hardwick SJ; Carpenter KL; Mitchinson MJ
    FEBS Lett; 1995 Jan; 358(2):175-8. PubMed ID: 7828731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-tocopherol supplementation of macrophages does not influence their ability to oxidize LDL.
    Baoutina A; Dean RT; Jessup W
    J Lipid Res; 1998 Jan; 39(1):114-30. PubMed ID: 9469591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages.
    Hunt JV; Bottoms MA; Taylor SE; Lyell V; Mitchinson MJ
    Free Radic Res; 1994 Mar; 20(3):189-201. PubMed ID: 8019642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein are inhibited by the inflammation marker 7,8-dihydroneopterin.
    Firth CA; Crone EM; Flavall EA; Roake JA; Gieseg SP
    Biochim Biophys Acta; 2008 Jun; 1783(6):1095-101. PubMed ID: 18342632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I; Grundy SM
    J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation.
    Thomas SR; Neuzil J; Stocker R
    Arterioscler Thromb Vasc Biol; 1996 May; 16(5):687-96. PubMed ID: 8963727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of oxysterols to human monocyte-macrophages.
    Clare K; Hardwick SJ; Carpenter KL; Weeratunge N; Mitchinson MJ
    Atherosclerosis; 1995 Nov; 118(1):67-75. PubMed ID: 8579633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy.
    O'Leary VJ; Tilling L; Fleetwood G; Stone D; Darley-Usmar V
    Atherosclerosis; 1996 Jan; 119(2):169-79. PubMed ID: 8808494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxidative modification of low-density lipoproteins by macrophages.
    Leake DS; Rankin SM
    Biochem J; 1990 Sep; 270(3):741-8. PubMed ID: 2122885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
    Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
    Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated oxidation of LDL: comparison of different cell types of the atherosclerotic lesion.
    Müller K; Carpenter KL; Mitchinson MJ
    Free Radic Res; 1998 Sep; 29(3):207-20. PubMed ID: 9802552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of oxidised low density lipoprotein towards mouse peritoneal macrophages in vitro.
    Reid VC; Mitchinson MJ
    Atherosclerosis; 1993 Jan; 98(1):17-24. PubMed ID: 8457247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carotenoids beta-carotene, canthaxanthin and zeaxanthin inhibit macrophage-mediated LDL oxidation.
    Carpenter KL; van der Veen C; Hird R; Dennis IF; Ding T; Mitchinson MJ
    FEBS Lett; 1997 Jan; 401(2-3):262-6. PubMed ID: 9013900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pre-existing redox profile of human macrophages on lipid synthesis and cholesteryl ester cycle in presence of native, acetylated and oxidised low density lipoprotein.
    Bravo E; Napolitano M; Rivabene R
    J Steroid Biochem Mol Biol; 2001 Apr; 77(1):73-81. PubMed ID: 11358676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein.
    Levy Y; Kaplan M; Ben-Amotz A; Aviram M
    Isr J Med Sci; 1996 Jun; 32(6):473-8. PubMed ID: 8682654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
    Rojstaczer N; Triggle DJ
    Biochem Pharmacol; 1996 Jan; 51(2):141-50. PubMed ID: 8615882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
    Hanna AN; Feller DR; Witiak DT; Newman HA
    Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-tocopherol consumption during low-density-lipoprotein oxidation.
    Jessup W; Rankin SM; De Whalley CV; Hoult JR; Scott J; Leake DS
    Biochem J; 1990 Jan; 265(2):399-405. PubMed ID: 2302177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.